Comparison of insulin degludec and glargine U100 in patients with type 1 diabetes prone to severe nocturnal hypoglycaemia

R Agesen; A Alibegovic; H Andersen; H Beck-Nielsen; P Gustenhoff; T Hansen; C Hedetoft; T Jensen; C Juhl; A Kryger; S Lerche; K Norgaard; H -H. Parving; A Sorensen; L Tarnow; B Thorsteinsson; U Pedersen-Bjergaard

doi:10.1089/dia.2020.2525.abstracts

Comparison of insulin degludec and glargine U100 in patients with type 1 diabetes prone to severe nocturnal hypoglycaemia

R Agesen, A Alibegovic, H Andersen, H Beck-Nielsen, P Gustenhoff, T Hansen, C Hedetoft, T Jensen, C Juhl, A Kryger, S Lerche, K Norgaard, H -H. Parving, A Sorensen, L Tarnow, B Thorsteinsson, U Pedersen-Bjergaard

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

178 Downloads (Pure)

Original language	English
Journal	Diabetes Technology & Therapeutics
Volume	22
Issue number	Suppl. 1
Pages (from-to)	A93-A94
Number of pages	2
ISSN	1520-9156
DOIs	https://doi.org/10.1089/dia.2020.2525.abstracts
Publication status	Published - Feb 2020
Event	International Conference on Advanced Technologies & Treatments for Diabetes, ATTD - Madrid, Spain Duration: 19 Feb 2020 → 22 Feb 2020 https://attd2020.kenes.com/

Conference

Conference	International Conference on Advanced Technologies & Treatments for Diabetes, ATTD
Country/Territory	Spain
City	Madrid
Period	19/02/2020 → 22/02/2020
Internet address	https://attd2020.kenes.com/

Bibliographical note

Abstract no. 280 / Abstract ID 793

Access to Document

10.1089/dia.2020.2525.abstracts

Agesen et al (2020) Comparison of insulin degludec and glargine U100 in patients with type 1 diabetes prone to severe nocturnal hypoglycaemiaFinal published version, 193 KB

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Agesen, R., Alibegovic, A., Andersen, H., Beck-Nielsen, H., Gustenhoff, P., Hansen, T., Hedetoft, C., Jensen, T., Juhl, C., Kryger, A., Lerche, S., Norgaard, K., Parving, H. -H., Sorensen, A., Tarnow, L., Thorsteinsson, B., & Pedersen-Bjergaard, U. (2020). Comparison of insulin degludec and glargine U100 in patients with type 1 diabetes prone to severe nocturnal hypoglycaemia. Diabetes Technology & Therapeutics, 22(Suppl. 1), A93-A94. https://doi.org/10.1089/dia.2020.2525.abstracts

@article{e4db0397260949f3acb2efeb6a9aca17,

title = "Comparison of insulin degludec and glargine U100 in patients with type 1 diabetes prone to severe nocturnal hypoglycaemia",

author = "R Agesen and A Alibegovic and H Andersen and H Beck-Nielsen and P Gustenhoff and T Hansen and C Hedetoft and T Jensen and C Juhl and A Kryger and S Lerche and K Norgaard and Parving, {H -H.} and A Sorensen and L Tarnow and B Thorsteinsson and U Pedersen-Bjergaard",

note = "Abstract no. 280 / Abstract ID 793; International Conference on Advanced Technologies & Treatments for Diabetes, ATTD ; Conference date: 19-02-2020 Through 22-02-2020",

year = "2020",

month = feb,

doi = "10.1089/dia.2020.2525.abstracts",

language = "English",

volume = "22",

pages = "A93--A94",

journal = "Diabetes Technology & Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

number = "Suppl. 1",

url = "https://attd2020.kenes.com/",

}

Agesen, R, Alibegovic, A, Andersen, H, Beck-Nielsen, H, Gustenhoff, P, Hansen, T, Hedetoft, C, Jensen, T, Juhl, C, Kryger, A, Lerche, S, Norgaard, K, Parving, H-H, Sorensen, A, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2020, 'Comparison of insulin degludec and glargine U100 in patients with type 1 diabetes prone to severe nocturnal hypoglycaemia', Diabetes Technology & Therapeutics, vol. 22, no. Suppl. 1, pp. A93-A94. https://doi.org/10.1089/dia.2020.2525.abstracts

TY - ABST

T1 - Comparison of insulin degludec and glargine U100 in patients with type 1 diabetes prone to severe nocturnal hypoglycaemia

AU - Agesen, R

AU - Alibegovic, A

AU - Andersen, H

AU - Beck-Nielsen, H

AU - Gustenhoff, P

AU - Hansen, T

AU - Hedetoft, C

AU - Jensen, T

AU - Juhl, C

AU - Kryger, A

AU - Lerche, S

AU - Norgaard, K

AU - Parving, H -H.

AU - Sorensen, A

AU - Tarnow, L

AU - Thorsteinsson, B

AU - Pedersen-Bjergaard, U

N1 - Abstract no. 280 / Abstract ID 793

PY - 2020/2

Y1 - 2020/2

U2 - 10.1089/dia.2020.2525.abstracts

DO - 10.1089/dia.2020.2525.abstracts

M3 - Conference abstract in journal

SN - 1520-9156

VL - 22

SP - A93-A94

JO - Diabetes Technology & Therapeutics

JF - Diabetes Technology & Therapeutics

IS - Suppl. 1

T2 - International Conference on Advanced Technologies & Treatments for Diabetes, ATTD

Y2 - 19 February 2020 through 22 February 2020

ER -